Delivery Order SPE2DB24D2106-SPE2DB25FAWLB
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $20,733.91 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Otezla 30 mg tablets (60-count packages). The delivery order, which carries no set-aside designation, is scheduled for completion by August 5, 2025, with performance to occur in Conshohocken, Pennsylvania. This award is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $22,541.73 by the Defense Logistics Agency on September 9, 2025, for the supply of Otezla 30 mg tablets (60-count packages). The delivery order, which carries no set-aside designation, is scheduled for completion by September 10, 2025, with performance occurring in Conshohocken, Pennsylvania. This award represents a task...
- The U.S. Defense Logistics Agency (DLA) awarded a $25,679.07 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the supply of 60-count bottles of Otezla 30 mg tablets, a pharmaceutical product used to treat certain medical conditions. This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract SPE2DB24D2106 with DLA, which has a ceiling value of up to $4,999,999 and enables...
- This federal contract award is a $5,435.86 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Otezla 30 mg tablets, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $41,446.37 to DMS Pharmaceutical Group Inc. for the supply of Otezla 30 mg tablets (60-count). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery to Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This delivery order was awarded without a set-aside designation on August 11, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Otezla 30 mg tablets (60 count) valued at $8,067.46 under a firm fixed-price contract type. The award was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and does not utilize a set-aside designation. DMS Pharmaceutical Group, based in Park Ridge, Illinois, will perform this delivery order from its Conshohocken,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,393.64 by the Defense Logistics Agency's Medical Supply Chain division on September 3, 2025, with an ultimate completion date of September 4, 2025. This delivery order carries no set-aside designation and represents a single task order issued under the company's larger Indefinite Delivery Contract with the DLA, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,827.98 by the Defense Logistics Agency (DLA) on August 29, 2025, with an ultimate completion date of September 2, 2025. This delivery order, issued without a set-aside designation, falls under the company's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which is valued at $499.999...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $26,499.12 by the Defense Logistics Agency's Medical Supply Chain division on September 10, 2025. This delivery order is issued under the company's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026. The award carries no...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $5,021.26 from the Defense Logistics Agency's Medical Supply Chain division on September 2, 2025. The delivery order, which carries no set-aside designation, is expected to be completed by September 8, 2025, and represents a continuation of the company's ongoing pharmaceutical distribution services to Department of Defense...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAWLBDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,210.71 by the Defense Logistics Agency (DLA) on September 12, 2025. The delivery order, which expires on September 15, 2025, is for the supply of Otezla 30 mg tablets (60-count units) to be delivered to Conshohocken, Pennsylvania. This award was issued without a set-aside designation, demonstrating the vendor's competitive capability in federal pharmaceutical procurement markets. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering specialized medications and medical supplies to military health facilities across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/12/25 |